{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:38:53Z","timestamp":1791113933261,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":3303,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ccr.2004.06.020","type":"journal-article","created":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T14:47:34Z","timestamp":1093272454000},"page":"7-10","source":"Crossref","is-referenced-by-count":144,"title":["Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes"],"prefix":"10.1016","volume":"6","author":[{"given":"James","family":"Brugarolas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William G","family":"Kaelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2004.06.020_BIB1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng904","article-title":"Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer","volume":"31","author":"Anand","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2004.06.020_BIB2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2004.05.024","article-title":"Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells","volume":"5","author":"Avdulov","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nature01045","article-title":"Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation","volume":"419","author":"Bardeesy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.06.020_BIB4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(03)00642-2","article-title":"LKB1, a protein kinase regulating cell proliferation and polarity","volume":"546","author":"Boudeau","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ccr.2004.06.020_BIB5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1535-6108(03)00187-9","article-title":"TSC2 regulates VEGF through mTOR-dependent and -independent pathways","volume":"4","author":"Brugarolas","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.06.020_BIB7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tibs.2003.11.005","article-title":"The AMP-activated protein kinase cascade\u2013a unifying system for energy control","volume":"29","author":"Carling","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ccr.2004.06.020_BIB8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s004390000348","article-title":"Molecular genetic advances in tuberous sclerosis","volume":"107","author":"Cheadle","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ccr.2004.06.020_BIB9","article-title":"Regulation of the TSC pathway by LKB1","volume":"in press","author":"Corrandeti","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2004.06.020_BIB10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ccr.2004.06.020_BIB11","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1038\/sj.onc.1207545","article-title":"eIF-4E expression and its role in malignancies and metastases","volume":"23","author":"De Benedetti","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2004.06.020_BIB12","first-page":"5173","article-title":"Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin","volume":"63","author":"El-Hashemite","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2004.06.020_BIB13","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"El-Hashemite","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccr.2004.06.020_BIB14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"Pten","volume":"22","author":"Eng","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ccr.2004.06.020_BIB15","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/sj.onc.1207542","article-title":"Target of rapamycin (TOR)","volume":"23","author":"Fingar","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2004.06.020_BIB16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1475-4924-2-28","article-title":"Complexes between the LKB1 tumor suppressor, STRAD\u03b1\/\u03b2 and MO25\u03b1\/\u03b2 are upstream kinases in the AMP-activated protein kinase cascade","volume":"2","author":"Hawley","year":"2003","journal-title":"J. Biol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/34432","article-title":"A serine\/threonine kinase gene defective in Peutz-Jeghers syndrome","volume":"391","author":"Hemminki","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.06.020_BIB18","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1207590","article-title":"Signaling control of mRNA translation in cancer pathogenesis","volume":"23","author":"Holland","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2004.06.020_BIB19","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1\u03b1 expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"Inoki","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ng0198-38","article-title":"Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase","volume":"18","author":"Jenne","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2004.06.020_BIB23","first-page":"363","article-title":"Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1","volume":"12","author":"Jiang","year":"2001","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.ccr.2004.06.020_BIB24","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1101\/gad.1003602","article-title":"How oxygen makes its presence felt","volume":"16","author":"Kaelin","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccr.2004.06.020_BIB25","doi-asserted-by":"crossref","unstructured":"Kaelin, W.G., Jr. (2004). Gleevec: Prototype or outlier? Sci STKE 2004, pe12.","DOI":"10.1126\/stke.2252004pe12"},{"key":"10.1016\/j.ccr.2004.06.020_BIB26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB27","doi-asserted-by":"crossref","unstructured":"Kondo, K., Kim, W.Y., Lechpammer, M., and Kaelin, W.G., Jr. (2003). Inhibition of HIF2\u03b1 is sufficient to suppress pVHL-defective tumor growth","DOI":"10.1371\/journal.pbio.0000083"},{"key":"10.1016\/j.ccr.2004.06.020_BIB28","first-page":"2675","article-title":"Up-regulation of hypoxia-inducible factor 2\u03b1 in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene","volume":"63","author":"Liu","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2004.06.020_BIB29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","article-title":"LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1","volume":"23","author":"Lizcano","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.ccr.2004.06.020_BIB30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nm1052","article-title":"mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways","volume":"10","author":"Majumder","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2004.06.020_BIB31","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1207549","article-title":"eIF4E\u2014from translation to transformation","volume":"23","author":"Mamane","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2004.06.020_BIB32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","article-title":"Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway","volume":"10","author":"Manning","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1535-6108(02)00044-2","article-title":"The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma","volume":"1","author":"Maranchie","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB34","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V90.9.3322","article-title":"Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase\/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element","volume":"90","author":"Mazure","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2004.06.020_BIB35","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1034\/j.1600-0560.2001.028009470.x","article-title":"Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis","volume":"28","author":"Nguyen-Vu","year":"2001","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ncb840","article-title":"Akt regulates growth by directly phosphorylating Tsc2","volume":"4","author":"Potter","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nm1042","article-title":"The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis","volume":"10","author":"Ruggero","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2004.06.020_BIB38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1535-6108(03)00275-7","article-title":"Will mTOR inhibitors make it as cancer drugs?","volume":"4","author":"Sawyers","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2004.06.007","article-title":"The LKB1 tumor suppressor negatively regulates mTOR signaling","volume":"6","author":"Shaw","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2004.06.020_BIB40","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.0308061100","article-title":"Inaugural Article","volume":"101","author":"Shaw","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2004.06.020_BIB41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.1073096","article-title":"Cancer. Addiction to oncogenes\u2013the Achilles heal of cancer","volume":"297","author":"Weinstein","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.06.020_BIB42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature02369","article-title":"Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy","volume":"428","author":"Wendel","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2004.06.020_BIB43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10434-001-0319-7","article-title":"Hamartomatous polyposis syndromes","volume":"8","author":"Wirtzfeld","year":"2001","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB44","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","article-title":"LKB1 is the upstream kinase in the AMP-activated protein kinase cascade","volume":"13","author":"Woods","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ccr.2004.06.020_BIB45","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1062074","article-title":"Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice","volume":"293","author":"Ylikorkala","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ccr.2004.06.020_BIB46","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2004.06.020_BIB47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1541-7786.89.2.2","article-title":"Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL\u2212\/\u2212 tumors","volume":"2","author":"Zimmer","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ccr.2004.06.020_BIB48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","article-title":"Loss of PTEN facilitates HIF-1-mediated gene expression","volume":"14","author":"Zundel","year":"2000","journal-title":"Genes Dev."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610804001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T01:43:43Z","timestamp":1705196623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610804001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1535610804001837"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2004.06.020","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}